Renaissance Technologies’s Diversified Healthcare Trust DHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.09M | Buy |
315,000
+62,200
| +25% | +$394K | ﹤0.01% | 1871 |
|
|
2025
Q4 | $1.23M | Buy |
252,800
+52,300
| +26% | +$237K | ﹤0.01% | 2163 |
|
|
2025
Q3 | $884K | Buy |
200,500
+125,500
| +167% | +$478K | ﹤0.01% | 2550 |
|
|
2025
Q2 | $269K | Buy |
75,000
+64,300
| +601% | +$186K | ﹤0.01% | 3079 |
|
|
2025
Q1 | $25.7K | Buy |
+10,700
| New | +$26.4K | ﹤0.01% | 3348 |
|
|
2024
Q4 | – | Sell |
-413,300
| Closed | -$1.73M | – | 3645 |
|
|
2024
Q3 | $1.73M | Buy |
413,300
+316,600
| +327% | +$1.07M | ﹤0.01% | 2117 |
|
|
2024
Q2 | $295K | Sell |
96,700
-65,100
| -40% | -$165K | ﹤0.01% | 2917 |
|
|
2024
Q1 | $398K | Buy |
161,800
+118,164
| +271% | +$338K | ﹤0.01% | 2963 |
|
|
2023
Q4 | $163K | Buy |
43,636
+20,736
| +91% | +$48.8K | ﹤0.01% | 3194 |
|
|
2023
Q3 | $44K | Buy |
+22,900
| New | +$58.1K | ﹤0.01% | 3424 |
|
|
2023
Q1 | – | Sell |
-1,223,683
| Closed | -$791K | – | 4052 |
|
|
2022
Q4 | $791K | Buy |
1,223,683
+377,983
| +45% | +$373K | ﹤0.01% | 2669 |
|
|
2022
Q3 | $837K | Sell |
845,700
-717,600
| -46% | -$1.15M | ﹤0.01% | 2606 |
|
|
2022
Q2 | $2.85M | Buy |
1,563,300
+830,100
| +113% | +$1.9M | ﹤0.01% | 1943 |
|
|
2022
Q1 | $2.35M | Buy |
+733,200
| New | +$2.24M | ﹤0.01% | 2123 |
|
|
2021
Q2 | – | Sell |
-711,600
| Closed | -$3.4M | – | 3518 |
|
|
2021
Q1 | $3.4M | Buy |
711,600
+655,631
| +1,171% | +$3.02M | ﹤0.01% | 1891 |
|
|
2020
Q4 | $231K | Buy |
+55,969
| New | +$221K | ﹤0.01% | 3100 |
|
|
2020
Q2 | – | Sell |
-169,100
| Closed | -$614K | – | 3498 |
|
|
2020
Q1 | $614K | Buy |
169,100
+12,700
| +8% | +$83.3K | ﹤0.01% | 2658 |
|
|
2019
Q4 | $1.32M | Sell |
156,400
-664,806
| -81% | -$5.6M | ﹤0.01% | 2508 |
|
|
2019
Q3 | $7.6M | Buy |
+821,206
| New | +$7.08M | 0.01% | 1565 |
|
|
2019
Q2 | – | Sell |
-18,100
| Closed | -$213K | – | 3582 |
|
|
2019
Q1 | $213K | Sell |
18,100
-676,900
| -97% | -$8.67M | ﹤0.01% | 3196 |
|
|
2018
Q4 | $8.14M | Sell |
695,000
-768,100
| -52% | -$11.4M | 0.01% | 1430 |
|
|
2018
Q3 | $25.7M | Buy |
1,463,100
+479,700
| +49% | +$8.81M | 0.03% | 776 |
|
|
2018
Q2 | $17.8M | Sell |
983,400
-53,600
| -5% | -$886K | 0.02% | 996 |
|
|
2018
Q1 | $16.2M | Sell |
1,037,000
-587,500
| -36% | -$9.77M | 0.02% | 1066 |
|
|
2017
Q4 | $31.1M | Buy |
1,624,500
+466,495
| +40% | +$8.93M | 0.03% | 670 |
|
|
2017
Q3 | $22.6M | Buy |
1,158,005
+213,505
| +23% | +$4.16M | 0.03% | 818 |
|
|
2017
Q2 | $19.3M | Buy |
944,500
+198,100
| +27% | +$4.23M | 0.02% | 871 |
|
|
2017
Q1 | $15.1M | Sell |
746,400
-109,900
| -13% | -$2.15M | 0.02% | 975 |
|
|
2016
Q4 | $16.2M | Buy |
856,300
+545,700
| +176% | +$10.6M | 0.03% | 917 |
|
|
2016
Q3 | $7.05M | Sell |
310,600
-41,100
| -12% | -$910K | 0.01% | 1395 |
|
|
2016
Q2 | $7.33M | Sell |
351,700
-468,500
| -57% | -$8.73M | 0.01% | 1350 |
|
|
2016
Q1 | $14.7M | Sell |
820,200
-527,000
| -39% | -$8.22M | 0.03% | 868 |
|
|
2015
Q4 | $20M | Buy |
1,347,200
+720,029
| +115% | +$10.8M | 0.04% | 550 |
|
|
2015
Q3 | $10.1M | Buy |
+627,171
| New | +$10.4M | 0.02% | 936 |
|
|
2015
Q1 | – | Sell |
-254,571
| Closed | -$5.58M | – | 3197 |
|
|
2014
Q4 | $5.58M | Buy |
254,571
+113,916
| +81% | +$2.5M | 0.01% | 1208 |
|
|
2014
Q3 | $2.92M | Buy |
+140,655
| New | +$3.19M | 0.01% | 1463 |
|
|
2014
Q2 | – | Sell |
-423,982
| Closed | -$9.44M | – | 2812 |
|
|
2014
Q1 | $9.44M | Buy |
+423,982
| New | +$9.27M | 0.02% | 899 |
|
Other funds holding DHC
FFL
SPC
H2CM
VCM
VPM
DKCM
Renaissance Technologies's DHC Position: Q1 2026 in Review
Renaissance Technologies increased its Diversified Healthcare Trust (DHC) stake by 25% in Q1 2026, buying an estimated $394K and bringing the position to 315,000 shares worth $2.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1871.
Renaissance Technologies first reported a position in DHC in Q1 2014 and has held it in 37 quarters since. The position peaked at $31.1M in Q4 2017. 230 funds tracked by Wall St. Rank hold DHC as of Q1 2026.
- Renaissance Technologies held 315,000 shares of Diversified Healthcare Trust worth $2.09M as of Q1 2026.
- Renaissance Technologies bought 62,200 Diversified Healthcare Trust shares in Q1 2026, an estimated $394K.
- Diversified Healthcare Trust made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #1871 holding.
- Renaissance Technologies first reported a position in Diversified Healthcare Trust in Q1 2014 and has held it in 37 quarters since.
- Renaissance Technologies's Diversified Healthcare Trust position peaked at $31.1M in Q4 2017.
- 230 funds tracked by Wall St. Rank held Diversified Healthcare Trust as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.